{
    "xml": "<topic id=\"PHP107704\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/lipegfilgrastim\" basename=\"lipegfilgrastim\" title=\"LIPEGFILGRASTIM\">\n<title>LIPEGFILGRASTIM</title>\n<body>\n<data name=\"vtmid\">24118511000001107</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_857996914\" title=\"Granulocyte-colony stimulating factors\">Granulocyte-colony stimulating factors</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34593\" title=\"GRANULOCYTE-COLONY STIMULATING FACTORS\" namespace=\"/drug-classes/granulocyte-colony-stimulating-factors\">GRANULOCYTE-COLONY STIMULATING FACTORS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<p outputclass=\"synonyms\">Glycopegylated recombinant methionyl human granulocyte-colony stimulating factor</p>\n</body>\n<topic id=\"PHP107715\" outputclass=\"indicationsAndDose\" rev=\"1.29\" parent=\"/drugs/lipegfilgrastim\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Reduction in duration of neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy for malignancy (except chronic myeloid leukaemia and myelodysplastic syndromes)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (specialist use only)</p>\n<p>6&#8239;mg, for each chemotherapy cycle, given approximately 24 hours after chemotherapy, dose expressed as filgrastim.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP107708\" outputclass=\"cautions\" rev=\"1.10\" parent=\"/drugs/lipegfilgrastim\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Myelosuppressive chemotherapy</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP107716\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/lipegfilgrastim\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (lipegfilgrastim).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP107721\" outputclass=\"sideEffects\" rev=\"1.8\" parent=\"/drugs/lipegfilgrastim\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hypokalaemia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP107704-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/lipegfilgrastim\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP107732\" title=\"Solution for injection\" namespace=\"/drugs/lipegfilgrastim/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107699\" namespace=\"/about/changes\" title=\"Changes\" count=\"1\" rel=\"backlink\">Changes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78575\" namespace=\"/treatment-summaries/neutropenia\" title=\"Neutropenia\" count=\"1\" rel=\"backlink\">Neutropenia</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34593\" namespace=\"/drug-classes/granulocyte-colony-stimulating-factors\" title=\"GRANULOCYTE-COLONY STIMULATING FACTORS\" count=\"1\" rel=\"link\">GRANULOCYTE-COLONY STIMULATING FACTORS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP107732\" namespace=\"/drugs/lipegfilgrastim/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP107704",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/lipegfilgrastim",
    "basename": "lipegfilgrastim",
    "title": "LIPEGFILGRASTIM",
    "vtmid": "24118511000001107",
    "drugClassification": [
        "Granulocyte-colony stimulating factors"
    ],
    "inheritsFromClass": [
        "GRANULOCYTE-COLONY STIMULATING FACTORS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Glycopegylated recombinant methionyl human granulocyte-colony stimulating factor"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Reduction in duration of neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy for malignancy (except chronic myeloid leukaemia and myelodysplastic syndromes)",
                        "html": "Reduction in duration of neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy for malignancy (except chronic myeloid leukaemia and myelodysplastic syndromes)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection"
                    ],
                    "textContent": "By subcutaneous injection",
                    "html": "By subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "6 mg, for each chemotherapy cycle, given approximately 24 hours after chemotherapy, dose expressed as filgrastim.",
                        "html": "<p>6&#8239;mg, for each chemotherapy cycle, given approximately 24 hours after chemotherapy, dose expressed as filgrastim.</p>",
                        "ageGroup": "(specialist use only)"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Myelosuppressive chemotherapy",
                "html": "Myelosuppressive chemotherapy"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (lipegfilgrastim).",
                "html": "<p>Appendix 1 (lipegfilgrastim).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Hypokalaemia",
                        "html": "Hypokalaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP107732",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "treatmentSummary": [
            {
                "id": "PHP107699",
                "label": "Changes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78575",
                "label": "Neutropenia",
                "type": "treatmentSummary"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "drugClass": [
            {
                "id": "PHP34593",
                "label": "GRANULOCYTE-COLONY STIMULATING FACTORS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP107732",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}